Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Treatment of osteosarcoma with Cisplatin and Doxorubicin either as Adjuvant or Neo-Adjuvant chemotherapy
Improved survival in osteosarcoma patients treated with Adjuvant chemotherapy was reported since the early 70s [1, 2]. However it was strongly disputed [3] and it was not until the 80s, after the results of ra...